JERUSALEM--(BUSINESS WIRE)--June 30, 2006--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA - News) announced today that the U.S. Food and Drug Administration has granted final approval for the Company’s Abbreviated New Drug Application (ANDA) to market its generic version of Pfizer’s Zoloft® (Sertraline) Tablets, 25 mg, 50 mg, and 100 mg.
